When To Consider Another COVID-19 Booster

Short Wave

NPR

Science, Life Sciences, News, Nature, Daily News, Astronomy

4.7 • 6.5K Ratings

🗓️ 5 April 2022

⏱️ 11 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week, U.S. Food and Drug Administration vaccine advisors will meet to discuss long-term COVID vaccine strategy. This follows the recent FDA authorization and CDC recommendation of a second booster available for people 50 and older and some immunocompromised people. Going forward, will the strategy change from counting boosters to making a COVID vaccine a seasonal shot? Allison Aubrey talks to Emily Kwong about the latest on boosters, what's known about the vaccination timeline for younger children, and what some experts are saying about the BA.2 variant.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy

Transcript

Click on a timestamp to play from that location

0:00.0	You're listening to shortwave from NPR.
0:06.0	Hey short waivers, I'm only quong here with a reminder that although some aspects of
0:11.5	indoor life perhaps have resumed for you like eating out and traveling and being out and
0:17.2	about, it can kind of seem like the pandemic is over, right?
0:21.0	But it's not.
0:22.0	This virus is still infecting people, which is why my girl Alice and Aubrey is here to catch
0:26.6	you up on where we are with ongoing vaccination and boosters in the US.
0:31.6	Hey there Emily, that's right.
0:33.0	This week, advisors to the Food and Drug Administration will meet to discuss the future
0:37.3	of COVID boosters in late March.
0:39.7	The US government approved a second booster for people 50 and over.
0:44.3	But considering that half of Americans haven't even received their first booster,
0:49.3	how do policymakers convince people to get more shots that may be beneficial?
0:55.6	You know, I think it might be tough.
0:57.4	But for those who think they might want to get one, we've got tips on how to decide
1:01.8	timing and whether to hold out for a variant specific booster.
1:06.2	Also the FDA is expecting more data to roll in from vaccine trials and kids under age
1:11.4	six.
1:12.4	But will this data be convincing enough to win authorization and sway parents?
1:17.9	Today on the show, Allison talks us through the US vaccination campaign and why it's so
1:23.0	important for ending the pandemic once and for all.
1:26.3	You're listening to Shortwave, the Daily Science podcast from NPR.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.